Last reviewed · How we verify
Polyethylene Glycol Ointment [Placebo] — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Polyethylene Glycol Ointment [Placebo] (Polyethylene Glycol Ointment [Placebo]) — US Department of Veterans Affairs. Polyethylene glycol ointment is an inert, occlusive topical vehicle that provides no active pharmacological effect and serves as a placebo control.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Polyethylene Glycol Ointment [Placebo] TARGET | Polyethylene Glycol Ointment [Placebo] | US Department of Veterans Affairs | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Polyethylene Glycol Ointment [Placebo] CI watch — RSS
- Polyethylene Glycol Ointment [Placebo] CI watch — Atom
- Polyethylene Glycol Ointment [Placebo] CI watch — JSON
- Polyethylene Glycol Ointment [Placebo] alone — RSS
Cite this brief
Drug Landscape (2026). Polyethylene Glycol Ointment [Placebo] — Competitive Intelligence Brief. https://druglandscape.com/ci/polyethylene-glycol-ointment-placebo. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab